Your browser doesn't support javascript.
Interferon lambda 3 in the early phase of coronavirus disease-19 can predict oxygen requirement.
Suzuki, Tetsuya; Iwamoto, Noriko; Tsuzuki, Shinya; Kakumoto, Yuko; Suzuki, Michiyo; Ashida, Shinobu; Oshiro, Yusuke; Nemoto, Takeshi; Kanda, Kohei; Okuhama, Ayako; Yamada, Gen; Inada, Makoto; Sato, Lubna; Miyazato, Yusuke; Akiyama, Yutaro; Saito, Sho; Morioka, Shinichiro; Ujiie, Mugen; Hayakawa, Kayoko; Sugiyama, Masaya; Mizokami, Masashi; Kodama, Eiichi N; Ohmagari, Norio.
  • Suzuki T; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
  • Iwamoto N; Emerging and Re-emerging Infectious Diseases, Graduate School of Medicine, Tohoku University, Sendai, Japan.
  • Tsuzuki S; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
  • Kakumoto Y; Emerging and Re-emerging Infectious Diseases, Graduate School of Medicine, Tohoku University, Sendai, Japan.
  • Suzuki M; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
  • Ashida S; Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
  • Oshiro Y; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
  • Nemoto T; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
  • Kanda K; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
  • Okuhama A; Clinical Laboratory Department, National Center for Global Health and Medicine, Tokyo, Japan.
  • Yamada G; Clinical Laboratory Department, National Center for Global Health and Medicine, Tokyo, Japan.
  • Inada M; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
  • Sato L; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
  • Miyazato Y; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
  • Akiyama Y; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
  • Saito S; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
  • Morioka S; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
  • Ujiie M; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
  • Hayakawa K; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
  • Sugiyama M; Emerging and Re-emerging Infectious Diseases, Graduate School of Medicine, Tohoku University, Sendai, Japan.
  • Mizokami M; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
  • Kodama EN; Emerging and Re-emerging Infectious Diseases, Graduate School of Medicine, Tohoku University, Sendai, Japan.
  • Ohmagari N; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
Eur J Clin Invest ; 52(9): e13808, 2022 09.
Article in English | MEDLINE | ID: covidwho-1819894
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: Eur J Clin Invest Year: 2022 Document Type: Article Affiliation country: Eci.13808

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: Eur J Clin Invest Year: 2022 Document Type: Article Affiliation country: Eci.13808